Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| STAAR SURGIC | STAA | 10.98% |
| DTS INC | DTSI | 6.89% |
| ANIKA THERAP | ANIK | 6.04% |
| LUMOS NETWOR | LMOS | 5.70% |
| INSTEEL IND | IIIN | 5.28% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
To enhance its operating efficiency, Canadian National Railway Company (CNI - Analyst Report)), which operates the largest rail network in Canada and the only transcontinental network in North America merged three of its operational units – Elgin, Joliet and Eastern Railway Company into its Wisconsin Central Ltd. (WC) subsidiary.
Canadian National remains highly optimistic about the merger as it will certainly boost its performance going forward.
Canadian National expects strong demand across all its businesses with improvement in wholesale and retail markets supporting high business volumes for the company. Based on which, in 2012, the company had planned to invest C$1.8 billion to upgrade its railway infrastructure project. So, opening of offices across the Southeast Asian countries is also a part of its aggressive growth plan.
Despite the slowing economy and stiff competition from Canadian Pacific Railway (CP - Analyst Report), we believe the improving operating efficiency along with expansion growth in key markets will help the company achieve strong financial results in the forthcoming quarters. This has underpinned mid-single digit carload growth and approximately 10% earnings growth in 2012. Management continues to expect a sustainable operating ratio, given stronger volume growth at low incremental cost with productivity initiatives like improving system velocity and fuel efficiency.
Currently, Canadian National Railway has a Zacks #4 Rank, implying a short-term Sell rating on the stock. For the long term, however, we maintain our Neutral recommendation on the stock.
Based in Montreal, Canada, Canadian National Railway Company is engaged in the rail and related transportation business.
Get the full Analyst Report on CNI - FREE
Get the full Analyst Report on CP - FREE